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Possible role of secreted proteinases
in Candida albicans infections
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Institute for General Botany, Applied Molecular Biology III, University of Hamburg, Germany.
Extracellular proteolytic activity of the human pathogen Candida albicans is due
to the activity of at least nine secreted aspartyl proteinase (Sap) isoenzymes.
SAP1-9 genes are differentially regulated both in vitro and in vivo at the transcrip-
tional level. All SAP genes are translated into preproenzymes, which are proces-
sed by a signal peptidase and a Kex2-like proteinase. In vitro experiments using
purified Saps suggested that active Saps may play a role in attachment, coloni-
zation, penetration of host tissues and immune evasion. In vivo expression of
SAP1-6 during oral candidosis was established. Using sap mutants, produced by
targeted gene disruption, a prominent role for SAP1-6 during murine dissemina-
ted infections and for SAP1-3 during rat vaginal infections could be demonstra-
ted. These data underline the general importance of extracellular proteinases for
the pathogenesis in C. albicans infections.
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Posible papel de las proteinasas secretadas en las
infecciones por Candida albicans
La actividad proteolítica extracelular del patógeno humano Candida albicans se
debe a la actividad de al menos nueve isoenzimas aspartil-proteinasas secreta-
das (Sap). Los genes SAP1-9 son regulados de manera diferencial tanto in vitro
como in vivo a nivel de transcripción. Todos los genes SAP se traducen en pre-
proenzimas que son procesados por una peptidasa señal y una proteinasa tipo
Kex2. Los experimentos in vitro con Saps purificadas sugieren que las Saps acti-
vas pueden jugar un papel en la adhesión, colonización, penetración de los teji-
dos del huésped y la evasión del sistema inmune. Se ha demostrado la
expresión in vivo de SAP1-6 durante la candidosis oral. Utilizando mutantes sap
producidos mediante interrupción del gen correspondiente, se pudo demostrar el
papel fundamental de SAP1-6 en la infección diseminada murina y de SAP1-3
en la infección vaginal en ratas. Estos datos subrayan la importancia general de
las proteinasas extracelulares en la patogénesis de las infecciones por C. albi-
cans.
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Proteolytic activity of the human pathogen
Candida albicans has been discussed as a virulence factor
since 1965 [1-3]. Strains with higher proteolytic activity
were shown to be more virulent [5,6,7,10], and proteina-
se-deficient mutants of C. albicans were less pathogenic
[4,11,12]. Although these observations associate secreted
aspartyl proteinases (Saps) of C. albicans with virulence,
this early picture was at least simplified. The last eight
years have demonstrated that the SAP gene family com-
prises at least nine members [13-19], but the majority of
purified proteinases [20-24] were shown to be products of
a single gene only (SAP2) [30,32]. Consequently, prote-
olytic activity measured under most in vitro conditions,
e.g. in medium with protein as the sole source of nitro-
gen, was due to Sap2 activity. Thus, correlations between
in vitro proteolytic activity and virulence may only reflect
secretion and activity of Sap2, rather than the other Sap
isoenzymes. In addition, the proteinase-deficient mutants
used in earlier studies were obtained by chemical or UV-
treatment and may harbour non-specific mutations at other
loci that may impair growth or reduce virulence. Also,
virulence studies using proteinase-deficient mutants were
focused on mouse models of disseminated candidosis, the-
refore it was not clear if proteinases would be important
for other types of infection such as mucosal candidosis.
The discovery of a SAP gene family [15] raised
questions about the roles of the nine different SAP genes.
For example, it has been postulated that the Sap isoenzy-
mes could function at different stages or during different
types of infections. With the availability of cloned SAP
genes and the application of molecular tools, such as tar-
geted gene disruption and RT-PCR technology, significant
progress has been made to clarify the regulation and
importance of C. albicans proteinases in vitro and in vivo.
Furthermore, recent studies using purified proteinases and
proteinase-specific antibodies give insights into the possi-
ble roles of these enzymes during infection.
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SAP EXPRESSION IN VITRO 
All members of the SAP gene family encode pre-
proenzymes, therefore, there are at least two possible
ways to regulate the expression of these proteins: regula-
tion at the mRNA- or protein- level. Sap preproenzymes
are processed and activated by a signal peptidase in the
endoplasmatic reticulum and a Kex2-like proteinase in the
late golgi compartment [25,26]. The KEX2 gene of
C. albicans has been recently cloned and disrupted, and
kex2 null mutants were shown to secrete active Sap2;
however, the enzyme was abnormally processed and
secreted at a reduced level [26]. This indicated that Kex2
is partially involved in processing Sap2, but alternative
Sap processing routes exist in C. albicans. However,
kinetic studies of Sap2 secretion by protein-labelling and
immunoprecipitation (pulse chase experiments) suggested
that proteinase synthesis and secretion were coupled and
no intracellular Sap forms were accumulated [27,28].
Therefore, regulation of Sap2 activity must occur predo-
minantly at the mRNA level.
SAP genes are regulated differentially in vitro at
the transcriptional level [3]. SAP1 and SAP3 are thought
to be regulated during phenotypic switching [29-32],
however, SAP3 mRNA was also detected in yeast cells of
some strains under conditions where SAP2 was highly
expressed [30,33]. SAP2 mRNA was the main transcript
in log-phase yeast cells and was induced by peptides
[30,32]. SAP4 - SAP6 were expressed in cells undergoing
yeast to hyphal transition at neutral pH [30,32], while
SAP7 was transcriptionally silent under all conditions tes-
ted in vitro [30]. Expression of SAP8 was increased at
25°C physiological temperatures [34], and transcripts of
SAP9 were observed preferentially in later growth phases,
when expression of other SAP genes had decreased [19].
This in vitro expression pattern suggested that various
members of the SAP gene family may have distinct roles
during Candida infections.
POSSIBLE TARGET PROTEINS OF SAPS
The most manifest property of Sap2 is its broad
substrate specificity, and this is likely the case for the
other Sap isoenzymes [35]. Only a few proteins, such as
lysozyme and ferritin, resist Sap2 activity [2], but the
majority of proteins such as keratin, collagen and vimen-
tin [36,37] can be degraded. Not only could this provide
essential nitrogen for growth, but could also enhance
attachment, colonization and penetration of host barriers.
For example, hydrolysis of mucin by Sap2 may help
C. albicans to penetrate the gastrointestinal mucosa [38],
and degradation of subendothelial extracellular matrix
proteins may aid invasion of endothelial cell layers [39].
A role for Sap2 during invasion of C. albicans
through endothelial cell layers was also demonstrated
using sap null mutants, obtained by targeted gene disrup-
tion. Only sap2 mutants caused significantly less endothe-
lial cell injury than the parental strain and sap1, sap3 or
sap4-6 mutants [40].
Adherence of C. albicans to human mucosa [41],
epidermal corneocytes [42] and epidermal keratinocytes
[43] has been shown to be inhibited by pepstatin A, a
potent inhibitor of aspartyl proteinases. Therefore, surface
proteins may be targets of the Saps. Each of the single
sap1, sap2, and sap3 null mutants were moderately less
adherent to buccal epithelial cells, suggesting that these
genes may act synergistically to enhance adherence [44[.
Surprisingly, a sap4-6 triple mutant had significantly
increased adherence. This may indicate that Sap4-6 nor-
mally remove or degrade cell surface components on the
yeast or epithelial cells that are inhibitory to the host-fun-
gus recognition and adhesion mechanism.
Adherence of the sap mutants to endothelial cells
was unaffected, indicating that Sap1-6 activity is not
essential [40]. However, it can not be excluded that in sin-
gle sap mutants a compensatory up-regulation of other
SAP genes occurs.
Many proteins of the immune system such as enzy-
mes of leucocytes (e.g. cathepsin D), immunoglobulins
(including secretory IgA), complement factors and alpha
macroglobulin are degraded by Sap2 [2,37,45]. Therefore,
Saps may help the fungus to evade the host immune sys-
tem. Recently this has been confirmed by Borg-von
Zepelin et al. [35], who showed that Sap4-6 are expressed
in murine macrophages. In addition, a sap4-6 triple
mutant was killed 53% more effectively after contact with
macrophages than the wild type strain, indicating a role
for Sap4-6 in this host-fungus interaction.
Finally, proteolytic activity of Sap2 could activate
host proteolytic cascades such as the blood clotting sys-
tem [8,9], which may not be advantageous to the fungus
but may have deleterious effects on the host.
These in vitro experiments illustrate the potential
of Sap activity. However, to elucidate the precise role of
Saps in pathogenicity, the expression, function and impor-
tance of each SAP gene during the Candida infection
must be investigated.
EXPRESSION AND RELEVANCE OF SAPS
DURING MUCOSAL INFECTIONS
The most common type of candidosis are mucosal
infections, such as infections of the oral cavity, the gas-
trointestinal tract and the vagina. Activity of Sap2, like
most aspartyl proteinases, was found to be optimal at aci-
dic pH values [3]. Since saliva has an approximately neu-
tral pH, it was thought that Saps may not be important in
oral candidosis. However, Sap4 - Sap6 are expressed and
active at neutral pH [30, 35], and Sap2 was shown to be
active at pH values near neutral [46]. Also, other Sap iso-
enzymes may act in acidic microniches [3]. A positive
correlation between C. albicans isolates from the oral
cavity of HIV positive patients and proteinase production
has been demonstrated by Ollert et al. [47] and De
Bernardis et al. [10]. In a skin model of human oral candi-
dosis Schaller et al. [48] showed a temporal regulation of
SAP expression by RT-PCR. The expression of SAP1,
SAP3 and SAP6 correlated temporally with severe lesions
of the epithelial tissue, suggesting a role of these SAP
genes in the first steps of an oral infection. It should be
noted that no SAP2 transcript was detected in the early
stages of infection, although SAP2 mRNA is the dominant
transcript under several in vitro conditions. Expression of
SAP1, SAP3 and SAP6 was also detected by RT-PCR in a
sample from a young female patient suffering from acute
oral candidosis at an early stage [48].
Sap production is thought to play a role in the
mechanisms by which C. albicans infects and persists in
the vagina. Expression of SAP1 and SAP2 has been
demontrated by Northern blotting in experimental vagini-
tis in rats [49], and polyclonal antibodies against Sap2
conferred partial protection in the same model [50].
Furthermore, sap2 null mutants were almost avirulent in
the rat vaginitis model [51]. In addition, the virulence of
sap1 and sap3, but not sap4 - sap6 null mutants, was atte-
nuated in comparison to the parental strain, indicating thatProteinases in Candida albicans
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SAP4-6 may not be important for this type of candidosis.
These data clearly demonstrate that distinct Sap isoenzy-
mes are essential for initiation and persistence of experi-
mental vaginitis.
ROLE OF SAPS IN DISSEMINATED INFECTIONS
Antigen-antibody studies provided the strongest
evidence that Saps are expressed during systemic candi-
dosis [52]. In a more recent study, when sap1, sap2 , sap3
and sap4-6 null mutants were injected intravenously in
guinea pigs and mice, the animals had increased survival-
rate compared to control animals infected with the paren-
tal strain [53,54]. However, reduction of proteolytic
activity in vitro did not correlate directly with the extent
of attenuation of virulence observed for all Sap-deficient
mutants. These data suggest that SAP1, SAP2, SAP3 and
SAP4-6 all contribute to the overall virulence of C. albi-
cans, and presumably all play important roles during dis-
seminated infections. For example, Sap2 may be needed
for invasion through the endothelial cell barrier [40] and
Sap4-6 for resistance to phagocytosis by macrophages
[35] (see above).
If Saps are important for disseminated candidosis,
the inhibition of these aspartyl proteinases in vivo will
protect the host against infection. Only slight or no pro-
tection by pepstatin A was observed when mice were
challenged intravenously [55,56]. In contrast, pretreat-
ment of neutropenic mice with pepstatin A by intraperito-
neal injection afforded strong dose-dependent protection
against a subsequent lethal intranasal dose of C. albicans
[56]. These data show that Saps may play an essential role
during early dissemination and suggest that aspartyl pro-
teinase inhibitors may prove useful as a prophylactic drug
to prevent systemic C. albicans infections.
CONCLUSIONS
Extracellular proteolytic activity of C. albicans is
due to the activity of at least nine SAP genes. Although
the substrate specificity of the Sap isoenzymes seem to be
similar, they differ in pH optima, thermal stability and,
more importantly, in expression pattern. [29-35,49]. It
seems that C. albicans provides a set of genes, whose
regulated expression allows the fungus to persist on diffe-
rent host surfaces, to resist host defence mechanisms and
to penetrate into deeper tissue [57,58]. Expression of dis-
tinct SAP genes during infection has been demonstrated
[48,49], and in one study inhibition of Saps efficiently
prevents disseminated infection [56]. In addition, the dis-
ruption of a single SAP gene (SAP2) produced a strain
avirulent in experimental vaginal infection. However, it
remains to be investigated which Saps are essential for
other types of infection. Further purification and characte-
rization of those essential Sap isoenzymes will allow the
future design of new Sap inhibitors with potential antican-
didal activity [33,37].
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